AP Biology

## Learning Outcomes

- Explain how CRISPR-Cas9 uses guide RNA and base-pairing to target a DNA sequence.
- Describe the role of Cas9 as a DNA-cutting enzyme and the need for a PAM sequence.
- Compare nonhomologous end joining and homology-directed repair after a Cas9 cut.
- Predict how CRISPR edits can affect mRNA, protein structure, gene expression, and phenotype.
- Interpret experimental designs involving CRISPR, controls, PCR, gel electrophoresis, or sequencing data.
- Identify common limitations of CRISPR-Cas9, including off-target edits and ethical concerns.

## AP Biology Syllabus

In AP Biology Unit 6, biotechnology is tested as part of gene expression and regulation, a unit that makes up about 12–16% of the multiple-choice section. CRISPR-Cas9 questions are unlikely to require obscure molecular details. Instead, expect to apply the central dogma, DNA base-pairing, mutations, gene regulation, and experimental design to a gene-editing scenario.

- Explain how DNA sequence information can be used to target a specific gene.
- Use complementary base-pairing rules to connect guide RNA with a DNA target.
- Predict whether an edit is likely to disrupt a gene, alter a protein, or change expression.
- Distinguish editing DNA from regulating transcription or translation.
- Connect CRISPR outcomes to mutation types such as insertions, deletions, frameshifts, and substitutions.
- Interpret biotechnology data from PCR, gel electrophoresis, sequencing, or phenotype measurements.
- Identify controls and variables in a CRISPR experiment.
- Evaluate possible benefits, risks, and limitations of genome editing.

## Test Your Knowledge

Attempt these questions before reading this article. If you find some difficult or cannot remember the answers, look more closely at that area during your revision.

1. What two main molecular components are needed for the basic CRISPR-Cas9 editing system?
2. Why does a Cas9 cut not automatically guarantee that a desired DNA sequence will be inserted?
3. How could a small insertion or deletion in the coding region of a gene produce a nonfunctional protein?
4. What is the difference between editing a gene in a somatic cell and editing a gene in a germline cell?
5. What control group could help show that a phenotype was caused by a CRISPR guide RNA rather than by the delivery method?

## Introduction

CRISPR-Cas9 is a biotechnology tool used to make targeted changes to DNA. In AP Biology, you should understand it as an application of several core Unit 6 ideas: DNA stores information in nucleotide sequences, RNA can base-pair with DNA, proteins carry out molecular functions, and mutations can change gene expression or phenotype.

The basic system uses a short RNA molecule to guide the Cas9 protein to a chosen DNA sequence. Cas9 then cuts the DNA. The cell’s own repair systems fix the break, and that repair process may disrupt a gene or, under some conditions, copy in a desired sequence.

> **Key Term: CRISPR-Cas9**
> A gene-editing system in which a guide RNA directs the Cas9 enzyme to a matching DNA sequence, where Cas9 cuts the DNA.

CRISPR-Cas9 originally comes from a bacterial defense system. Bacteria can store short pieces of viral DNA in CRISPR regions of their genome. If a related virus attacks later, RNA made from those stored sequences helps Cas proteins recognize and cut the viral genetic material. Scientists adapted this natural system into a tool for editing genomes in many organisms.

### How CRISPR-Cas9 Targets DNA

The central idea behind CRISPR-Cas9 targeting is complementary base-pairing. A guide RNA is designed with a sequence that can pair with the DNA target sequence. If the guide RNA and the DNA target match closely enough, Cas9 is brought to that location.

> **Key Term: guide RNA**
> An RNA molecule that contains a sequence complementary to a target DNA sequence and directs Cas9 to that location.

In many simplified AP-level explanations, the guide RNA is described as having about 20 nucleotides that match the chosen target by complementary base-pairing. For example, if a region of DNA includes the sequence:

```text
DNA target strand:  5'-A C G T T A C C G A T T C A G T A A C G-3'
guide RNA:          3'-U G C A A U G G C U A A G U C A U U G C-5'
```

The guide RNA uses RNA bases, so it contains uracil instead of thymine. The matching is still based on the same pairing logic: A pairs with U in RNA-DNA pairing, and C pairs with G.

Cas9 does not cut every DNA sequence that partly matches the guide RNA. For the commonly discussed Cas9 from _Streptococcus pyogenes_, the target sequence must be next to a short DNA sequence called a PAM. A common PAM for this Cas9 is NGG, where N can be any nucleotide. Different Cas proteins may use different PAM sequences, so exam questions usually provide the needed details if the exact PAM matters.

> **Key Term: PAM**
> A short DNA sequence next to the target site that is required for Cas9 binding and cutting; for a commonly used Cas9, NGG is a typical PAM.

A basic CRISPR-Cas9 editing process can be described in steps:

1. A target DNA sequence is chosen, often within or near a gene of interest.
2. A guide RNA is designed to be complementary to that target.
3. Cas9 and the guide RNA are delivered into cells.
4. The guide RNA-Cas9 complex binds near a PAM and checks for sequence matching.
5. Cas9 cuts both DNA strands at or near the target.
6. The cell repairs the broken DNA, which may create an edit.

> **Test Tip:**
> In AP questions, focus on cause and effect: the guide RNA provides sequence specificity, Cas9 cuts DNA, and the cell’s repair pathway determines the final edit.

Cas9 is not RNA polymerase, DNA polymerase, or a ribosome. It does not transcribe DNA into RNA or translate mRNA into protein. It is best understood as a DNA-cutting enzyme guided by RNA.

> **Exam Warning:**
> Do not write that CRISPR “turns genes on and off” as its only function. CRISPR-Cas9 edits DNA. A DNA edit may then change gene expression, mRNA sequence, protein sequence, or phenotype.

### DNA Repair Determines the Edit

The Cas9 cut is only the start of gene editing. A double-strand break in DNA is dangerous to a cell, so the cell repairs it quickly. The two repair pathways most often discussed with CRISPR-Cas9 are nonhomologous end joining and homology-directed repair.

> **Key Term: nonhomologous end joining**
> A DNA repair pathway that joins broken DNA ends directly and often creates small insertions or deletions.

Nonhomologous end joining, often abbreviated NHEJ, is useful when the goal is to disrupt a gene. This repair pathway does not require a matching DNA template. Because the repair can be imprecise, it may add or remove a few nucleotides at the cut site. These small insertions or deletions are called indels.

If an indel occurs in a protein-coding sequence, it may change the reading frame. A frameshift changes how codons are read from the mutation onward. This can alter many amino acids and may create an early stop codon. The resulting protein may be shorter, folded incorrectly, or nonfunctional.

For example, suppose the original mRNA sequence is:

```text
AUG-AAA-GCU-CGA-UAA
Met-Lys-Ala-Arg-Stop
```

If one nucleotide is deleted near the start, the codon grouping may change:

```text
AUG-AAG-CUC-GAU-AA...
Met-Lys-Leu-Asp-...
```

The ribosome reads mRNA in groups of three, so a single-nucleotide insertion or deletion can affect every codon after the mutation. This is why CRISPR edits made by NHEJ are often used to “knock out” a gene.

> **Key Term: homology-directed repair**
> A DNA repair pathway that uses a homologous DNA template to repair a break and can copy a desired sequence into the genome.

Homology-directed repair, often abbreviated HDR, is used when scientists want a precise DNA change. In this method, researchers provide a donor DNA template with the desired sequence. The cell can use that template to repair the Cas9-induced break, copying the new sequence into the genome.

HDR can be used to replace a disease-associated allele with a non-disease sequence, add a tag to a protein, or insert a gene segment. However, HDR is often less efficient than NHEJ in many cells. The cell may repair the break by NHEJ even when a donor template is present.

> **Exam Warning:**
> A Cas9 cut does not automatically insert the desired DNA sequence. Precise insertion usually requires a donor template and the appropriate DNA repair pathway.

This distinction matters on the exam. If a question says Cas9 cuts a gene but gives no donor template, the most likely outcome is small insertions or deletions caused by NHEJ. If the question says researchers provide a repair template, then HDR may be involved.

### Predicting Effects on Gene Expression and Phenotype

CRISPR-Cas9 can affect phenotype in different ways depending on where the edit occurs. AP Biology questions often test whether you can connect a DNA-level change to RNA, protein, cell function, and phenotype.

> **Key Term: genome editing**
> The deliberate alteration of DNA sequences in an organism’s genome.

If CRISPR disrupts a coding sequence, the edit may change the amino acid sequence of the protein. A frameshift or premature stop codon often reduces protein function. A missense mutation may change one amino acid; its effect depends on whether that amino acid is needed for the protein’s shape or active site. A silent mutation may not change the amino acid because the genetic code is redundant.

If CRISPR edits a promoter, enhancer, silencer, or other regulatory sequence, the protein sequence may stay the same, but the amount, timing, or location of gene expression may change. For example, deleting an enhancer could reduce transcription of a gene in a particular cell type. This connects CRISPR to eukaryotic gene regulation, where regulatory proteins bind DNA sequences to increase or decrease transcription.

If CRISPR edits an intron, the effect may be small, but it is not always zero. Some introns contain regulatory sequences, and mutations near splice sites can alter RNA processing. AP questions should provide enough information to decide whether an intron mutation affects the final mRNA.

Here are common CRISPR outcomes and their likely AP-level interpretations:

- **Small insertion or deletion in an exon:** may cause a frameshift and nonfunctional protein.
- **Three-base deletion in an exon:** removes one amino acid but does not shift the reading frame.
- **Substitution in a codon:** may be silent, missense, or nonsense depending on the codon change.
- **Deletion of an enhancer:** may reduce transcription of a gene.
- **Edit in a promoter:** may affect RNA polymerase binding and change mRNA production.
- **Edit in a stem cell:** may affect many descendant cells.
- **Edit in a gamete or early embryo:** may be inherited by offspring.

> **Key Term: off-target effect**
> An unintended edit at a DNA sequence similar to the intended target sequence.

Off-target effects occur when the guide RNA-Cas9 complex cuts a site that is similar, but not identical, to the intended target. This can create unintended mutations. Scientists reduce off-target effects by choosing guide RNAs carefully, checking genome sequences for similar sites, using modified Cas9 enzymes, and confirming edits by sequencing.

CRISPR can also produce mosaic individuals when editing occurs in an embryo after the first cell division. In a mosaic organism, some cells carry the edit and others do not. This matters when predicting phenotype, because not all tissues may have the same genotype.

> **Test Tip:**
> When predicting phenotype, identify the affected biological level first: DNA sequence, mRNA amount, mRNA sequence, protein structure, protein activity, cell behavior, or whole-organism trait.

### Experimental Design, Applications, and Ethics

CRISPR-Cas9 is often tested through experimental scenarios rather than direct recall. You may be asked to identify controls, analyze data, or predict results.

A typical CRISPR experiment might ask whether gene X is required for pigment production in a plant. Researchers could design a guide RNA targeting gene X, deliver Cas9 and the guide RNA into plant cells, regenerate plants, and compare pigment levels with controls.

Good controls could include:

- **Untreated cells:** show the normal phenotype.
- **Cells receiving Cas9 but no guide RNA:** show whether Cas9 delivery alone affects the phenotype.
- **Cells receiving a non-targeting guide RNA:** show whether guide RNA delivery or cell treatment affects the phenotype.
- **Positive control with a known pigment gene disrupted:** shows the method can produce the expected loss of pigment.

The independent variable is usually the treatment, such as which guide RNA is used. The dependent variable might be pigment amount, mRNA level, protein level, enzyme activity, survival rate, or percentage of edited cells.

Scientists can confirm CRISPR edits in several ways. PCR can amplify the target region. Gel electrophoresis can sometimes detect large insertions or deletions by fragment size. DNA sequencing gives more direct evidence of the exact nucleotide change. Measurements of mRNA, protein, or phenotype can show the biological effect, but they do not by themselves prove the exact DNA edit.

For example, if CRISPR is used to disrupt a gene coding for an enzyme, the expected results might be:

- The DNA sequence at the target site contains an indel.
- The mRNA level may stay the same if transcription is unaffected.
- The protein may be shorter or absent if the mutation creates an early stop codon.
- Enzyme activity may decrease.
- The phenotype linked to that enzyme may change.

This is a key AP skill: do not assume every level changes in the same way. A mutation can alter protein function without changing mRNA amount. A regulatory edit can reduce mRNA and protein without changing the coding sequence.

CRISPR has many applications. In research, it can be used to knock out genes and study their functions. In medicine, it can be used to edit somatic cells, such as blood stem cells, to treat genetic diseases. One example is editing patient stem cells so their descendants produce a helpful form of hemoglobin. In agriculture, CRISPR may be used to create crops with altered disease resistance, nutritional traits, or growth characteristics.

CRISPR also raises ethical and safety questions. Editing somatic cells affects the treated individual but is generally not inherited. Editing germline cells, such as sperm, eggs, or embryos, can pass changes to future generations. Concerns include unintended mutations, unequal access to therapies, consent for future individuals, and ecological effects if edited organisms spread in natural populations.

> **Key Term: germline editing**
> Genetic alteration of gametes, embryos, or reproductive-line cells that can be inherited by future generations.

A special case is the use of CRISPR in gene drives, where an edit is designed to spread through a population faster than normal Mendelian inheritance would predict. This could, in theory, reduce disease-carrying mosquito populations, but it also raises concerns about effects on food webs and species interactions.

For the exam, you do not need to take a political position. You should be able to describe a scientifically valid benefit or risk and connect it to inheritance, mutation, population effects, or gene expression.

## Key Point Checklist

This article has covered the following key knowledge points:

- CRISPR-Cas9 is a biotechnology tool for targeted DNA editing.
- A guide RNA directs Cas9 to a DNA sequence by complementary base-pairing.
- Cas9 cuts DNA, but the cell’s repair pathway determines the final edit.
- A PAM sequence is required for many Cas9 systems to bind and cut the target.
- Nonhomologous end joining often creates small insertions or deletions.
- Indels in coding regions can cause frameshifts and nonfunctional proteins.
- Homology-directed repair can copy a desired sequence from a donor template.
- CRISPR edits can affect coding sequences, regulatory sequences, mRNA levels, protein function, or phenotype.
- Off-target effects are unintended edits at similar DNA sequences.
- AP questions often test CRISPR through experimental design, controls, data interpretation, and predictions.
- Somatic editing affects the treated individual, while germline editing can be inherited.
- Sequencing gives direct evidence of a DNA edit; phenotype alone does not prove the exact mutation.

## Key Terms and Concepts

- CRISPR-Cas9
- guide RNA
- PAM
- nonhomologous end joining
- homology-directed repair
- genome editing
- off-target effect
- germline editing


Biotechnology - CRISPR-Cas9